Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 317

Results For "IMI"

3570 News Found

EVA Pharma to open vaccine manufacturing facility in Cairo
Supply Chain | November 09, 2021

EVA Pharma to open vaccine manufacturing facility in Cairo

The new facility will provide an important boost to vaccine capacity in Africa


First clinical use of Lucent 3D Lumber successful
Medical Device | November 09, 2021

First clinical use of Lucent 3D Lumber successful

The Lucent 3D Lumbar Interbody System features a functionally unique multi-component device manufactured in a 3D printing sequence


Divis Labs PAT at Rs 606.46 cr. in Q2FY22
News | November 08, 2021

Divis Labs PAT at Rs 606.46 cr. in Q2FY22

Divi's Laboratories Limited has reported consolidated financial results for the period ended September 30, 2021.


Pfizer’s Covid-19 drug a potential game changer
Biotech | November 08, 2021

Pfizer’s Covid-19 drug a potential game changer

In the overall study population through Day 28, no deaths were reported in patients who received Paxlovid as compared to 10 deaths in patients who received placebo


Govt places orders for one crore doses of ZyCoV-D
News | November 08, 2021

Govt places orders for one crore doses of ZyCoV-D

It is the world’s first DNA-based Covid vaccine


Meiji Seika Pharma to build new facility in Bangalore to expand CMO business
Biotech | November 08, 2021

Meiji Seika Pharma to build new facility in Bangalore to expand CMO business

The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23


Novaerus devices reduce bio-burden in healthcare facilities: Dilip Patil, Partner, Trivector Biomed
interviews | November 05, 2021

Novaerus devices reduce bio-burden in healthcare facilities: Dilip Patil, Partner, Trivector Biomed

Trivector Biomed has been promoting its Novaerus air disinfection solution across hospitals and health care facilities across India.


UK authorises first Covid-19 pill
News | November 05, 2021

UK authorises first Covid-19 pill

Applications remain under review by others including U.S. Food and Drug Administration and the European Medicines Agency


Prime Therapeutics to list Semglee and Insulin Glargine
News | November 05, 2021

Prime Therapeutics to list Semglee and Insulin Glargine

Biocon Biologics and Viatris co-developed the products


SOPHiA Genetics launches SOPHiA DDM to assist Agilent customers
Digitisation | November 02, 2021

SOPHiA Genetics launches SOPHiA DDM to assist Agilent customers

New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation